Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Menopause. 2015 Oct;22(10):1045–1052. doi: 10.1097/GME.0000000000000430

Figure 1.

Figure 1

Percent change from baseline in fat-free mass and fat mass measured by DXA in response to 5 months of GnRHAG therapy with placebo or estradiol treatment (Panel A) and resistance exercise training or no exercise (Panel B). * p<0.05, within-group change; ‡ p <0.05, between-group difference.